Fewer Adverse Renal Effects With NOACs Than Warfarin in Non-Valvular Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Non-Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non-Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
J Am Heart Assoc 2021 Mar 17;[EPub Ahead of Print], P Sitticharoenchai, K Takkavatakarn, S Boonyaratavej, K Praditpornsilpa, S Eiam-Ong, P SusantitaphongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.